Long-term efficacy and safety of atenolol for supraventricular tachycardia in children

Pediatric Cardiology

Volumn 17, Issue 4, 1996, Pages 231-236

  Mehta, A V ^a   Subrahmanyam, A B ^a   Anand, R ^a  

^a East Tennessee State University   (United States)

Author keywords

Atenolol; Supraventricular tachycardia in children; Wolff Parkinson White syndrome

Indexed keywords

AMIODARONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; FLECAINIDE; NADOLOL; PROCAINAMIDE; PROPRANOLOL;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COLIC; DIARRHEA; DOSE RESPONSE; DREAMING; DROWSINESS; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG SAFETY; DRUG SELECTIVITY; FATIGUE; FEMALE; HEADACHE; HUMAN; INFANT; LONG TERM CARE; MALE; ORAL DRUG ADMINISTRATION; SUPRAVENTRICULAR TACHYCARDIA; WOLFF PARKINSON WHITE SYNDROME;

EID: 0029896205     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02524799     Document Type: Article

References (16)

1. Buck ML, Wiest D, Gillette PC, et al. (1989) Pharmacokinetics and pharmacodynamics of atenolol in children. Clin Pharmacol Ther 46, 629-633
2. Chang MS, Sung RJ, Tai TY, et al. (1983) Nadolol and supraventricular tachycardia: an electrophysiologic study. J Am Coll Cardiol 2:894-903
3. Di Biase M, Favale S, Rizzon P (1979) Electrophysiologic properties of intravenous Tenurmin in man. Eur J Cardiol 9:333-342
4. Frieden J, Rosenblum R, Enselberg CD, Rosenberg A (1968) Propranolol treatment of chronic intractable supraventricular arrhythmias. Am J Cardiol 22:711-717
5. Frishman W, Silverman R (1979) Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and meta-bolic effects. Am Heart J 97.797-807
6. Gettes LS, Yoshonis KF (1970) Rapidly recurring supraventricular tachycardia: a manifestation of reciprocating tachycardia and an indication for propranolol therapy. Circulation 47:689-700
7. Gillette P, Garson A Jr, Eterovic E, et al. (1978) Oral propranolol treatment in infants and children. J Pediatr 92:141-144
8. Lindsay BD, Saksena S, Rothbart ST, Herman S, Barr MJ (1987) Long-term efficacy and safety of beta-adrenergic receptor antagonists for supraventricular tachycardia. Am J Cardiol 60:63D-67D
9. Ludomirsky A, Garson A Jr (1990): Supraventricular tachycardia. In: Gillette PC, Garson A Jr (eds) Pediatric Arrhythmias, Electrophysiology and Pacing. Saunders, Philadelphia, pp 380-426
10. Mason WD, Winer N, Kochak G, Cohen I, Bell R (1979) Kinetics and absolute bioavailability of atenolol. Clin Pharmacol Ther 25: 408-415
11. Mehta AV, Chidambaram B (1992) Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children. J Am Coll Cardiol 19:630-635
12. Pickoff AS, Zies L, Ferrer PL, et al (1979) High-dose propranolol therapy in the management of supraventricular tachycardia. J Pediatr 94:144-146
13. Pimenta J, Pereira CB (1986) Effects of atenolol in patients with reciprocating supraventricular tachycardia Clin Cardiol 9:191-195
14. Robinson C, Birkhead J, Crook B, Jennings K, Jewitt D (1978) Clinical electrophysiologic effects of atenolol - a new cardioselective beta blocking agent. Br Heart J 40:14-21
15. Trippel DL, Gillette PC (1989) Atenolol in children with supraventricular tachycardia. Am J Cardiol 64:233-236
16. Wood AJJ (1984) Pharmacologic differences between beta blockers. Am Heart J 108:1070-1077